199 related articles for article (PubMed ID: 29533007)
21. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer.
Hervouet E; Cízková A; Demont J; Vojtísková A; Pecina P; Franssen-van Hal NL; Keijer J; Simonnet H; Ivánek R; Kmoch S; Godinot C; Houstek J
Carcinogenesis; 2008 Aug; 29(8):1528-37. PubMed ID: 18515279
[TBL] [Abstract][Full Text] [Related]
22. Houttuynia cordata Thunb Promotes Activation of HIF-1A-FOXO3 and MEF2A Pathways to Induce Apoptosis in Human HepG2 Hepatocellular Carcinoma Cells.
Kim JM; Hwang IH; Jang IS; Kim M; Bang IS; Park SJ; Chung YJ; Joo JC; Lee MG
Integr Cancer Ther; 2017 Sep; 16(3):360-372. PubMed ID: 27698266
[TBL] [Abstract][Full Text] [Related]
23. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis.
Zhao L; Li W; Zhou Y; Zhang Y; Huang S; Xu X; Li Z; Guo Q
Free Radic Biol Med; 2015 May; 82():29-41. PubMed ID: 25656992
[TBL] [Abstract][Full Text] [Related]
24. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
[TBL] [Abstract][Full Text] [Related]
25. Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src-Akt-LKB1-AMPKα pathway.
Nam K; Oh S; Shin I
Biochem J; 2016 Oct; 473(19):3013-30. PubMed ID: 27458252
[TBL] [Abstract][Full Text] [Related]
26. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
27. Immune effects of glycolysis or oxidative phosphorylation metabolic pathway in protecting against bacterial infection.
Li Y; Jia A; Wang Y; Dong L; Wang Y; He Y; Wang S; Cao Y; Yang H; Bi Y; Liu G
J Cell Physiol; 2019 Nov; 234(11):20298-20309. PubMed ID: 30972784
[TBL] [Abstract][Full Text] [Related]
28. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
29. HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism.
Lambert CM; Roy M; Robitaille GA; Richard DE; Bonnet S
Cardiovasc Res; 2010 Oct; 88(1):196-204. PubMed ID: 20498255
[TBL] [Abstract][Full Text] [Related]
30. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
31. Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells.
Zhdanov AV; Dmitriev RI; Golubeva AV; Gavrilova SA; Papkovsky DB
Biochim Biophys Acta; 2013 Jun; 1830(6):3553-69. PubMed ID: 23462283
[TBL] [Abstract][Full Text] [Related]
32. Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes.
Kihira Y; Yamano N; Izawa-Ishizawa Y; Ishizawa K; Ikeda Y; Tsuchiya K; Tamaki T; Tomita S
Int J Biochem Cell Biol; 2011 Nov; 43(11):1602-11. PubMed ID: 21810481
[TBL] [Abstract][Full Text] [Related]
33. Low oxygen level increases proliferation and metabolic changes in bovine granulosa cells.
Shiratsuki S; Hara T; Munakata Y; Shirasuna K; Kuwayama T; Iwata H
Mol Cell Endocrinol; 2016 Dec; 437():75-85. PubMed ID: 27519633
[TBL] [Abstract][Full Text] [Related]
34. Ochratoxin A induces reprogramming of glucose metabolism by switching energy metabolism from oxidative phosphorylation to glycolysis in human gastric epithelium GES-1 cells in vitro.
Wang Y; Zhao M; Cui J; Wu X; Li Y; Wu W; Zhang X
Toxicol Lett; 2020 Oct; 333():232-241. PubMed ID: 32835834
[TBL] [Abstract][Full Text] [Related]
35. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
36. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
37. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
[TBL] [Abstract][Full Text] [Related]
38. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Chen F; Zhuang M; Zhong C; Peng J; Wang X; Li J; Chen Z; Huang Y
Oncol Rep; 2015 Jan; 33(1):457-63. PubMed ID: 25333894
[TBL] [Abstract][Full Text] [Related]
39. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
[TBL] [Abstract][Full Text] [Related]
40. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
